1 Min Read
Sept 24 (Reuters) - HBM Healthcare Investments AG:
* SUCCESSFUL IPO OF Y-MABS THERAPEUTICS INCREASES NET ASSET VALUE PER HBM-SHARE BY CHF 4.82 (+2.7%) Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.